Skip to main content
S&P 5007,663.60+0.95%DOW52,538.72+0.91%NASDAQ26,377.47+1.13%BTC$78,586.00+1.65%ETH$2,605.82+6.74%GOLD$4,411.90+0.10%OIL$99.61-2.80%
Smart Investors Daily
Biostage, Inc. logo

OTC · BSTG

Biostage, Inc.

Healthcare · Biotechnology

$4.03

Up+$0.03 (+0.75%)

Updated Sep 11, 2026, 3:08 PM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
57.82M
P/E ratio
-9.6
Dividend yield
0.00%
52-week range
— – —
Volume
4.53K
Avg. volume
1.02K

Price performance

BSTG price history

1M range · 0 trading sessions · Daily adjusted prices

BSTG does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest BSTG news

The latest Smart Investors Daily articles mentioning BSTG.

Stock researchCompany · Overview

BSTG research

Overview

Company profile and research snapshot.

Company profile

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company is engaged in developing Biostage Esophageal Implant for the treating esophageal cancer. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

defenseworld.net · Dec 5, 2025

Critical Comparison: Arch Therapeutics (OTCMKTS:ARTH) vs. Biostage (OTCMKTS:BSTG)

Arch Therapeutics (OTCMKTS:ARTH - Get Free Report) and Biostage (OTCMKTS:BSTG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, analyst recommendations, valuation and risk. Volatility and Risk Arch Therapeutics has a beta

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By